Mobile ECG specialist AliveCor seeks US Apple Watch ban


AliveCor, a company that markets consumer EKG hardware and services, goes a step further with a complaint with the US International Trade Commission.

The mobile EKG company is requesting an import ban on all infringing Apple Watch models, including the Apple Watch Series 4 and Apple Watch Series 5. Apple's newest Apple Watch Series 6 was not named in an earlier lawsuit on which the complaint is based, though this is possible presumed that the device is in the crosshairs of AliveCor.

AliveCor announced in a statement released Tuesday that filing with the ITC "is a move, including AliveCor, to gain relief for Apple's deliberate copying of AliveCor's patented technology - including the ability to take an EKG reading on Apple Watch and perform heart rate analysis - as well as Apple's efforts to eliminate AliveCor as a competitor in the heart rate analysis market for the Apple Watch. "

Yesterday's press release touts a decade of investment in "advanced cardiac detection with AI," painting AliveCor's KardiaMobile, KardiaBand, KardiaMobile 6L and SmartRhythm AI as market-changing products. KardiaMobile, for example, is hailed by its manufacturer as the "most clinically validated" consumer EKG in the world, while KardiaBand - ironically - was the first FDA-approved medical device accessory for the Apple Watch.

AliveCor filed a lawsuit against Apple in December alleging the technology giant's integration of EKG hardware and supporting software violated three patents that set out methods of detecting and monitoring cardiac arrhythmias using portable devices.

The Apple Watch's EKG functionality is designed to detect a potentially fatal heart condition called atrial fibrillation (AFib) using technology similar to a one-lead electrocardiogram. The device has been credited with saving several lives, a fact that Apple regularly refers to and sometimes puts in the spotlight on special events.

AliveCor has been following Apple since the Apple Watch Series 4 launched in 2018. Prior to the wearable's release, AliveCor led the FDA-cleared hardware EKG segment with FDA-cleared hardware and advanced detection software. After Apple entered the category, AliveCor launched a media offensive, telling media outlets, including AppleInsider, that it was the first company to receive FDA approval. While AliveCor's solution required a doctor to review and "unlock" the device's first EKG reading, Apple does not.

The company stopped selling the Apple Watch-Tagalong KardiaBand in August 2019 and decided to focus on other mobile solutions.


continue reading https://dailytechnonewsllc.com/mobile-ecg-specialist-alivecor-seeks-us-apple-watch-ban/?feed_id=6005&_unique_id=61cf9ab6a17ac

Commentaires

Enregistrer un commentaire

Posts les plus consultés de ce blog

Projections for the gambling industry for 2022

Image
W. ith 2021, which is almost behind us, it is time to look ahead to 2022. While it will be a few more months, most business people are already planning strategies for what lies ahead. These were exciting years with many unpredictable events and trends. We have seen how digital currencies, virtual reality, esports, live dealer games, IoT and many other technologies have found their place in the industry. The importance of cell phones to the gambling industry has also been shown. What else have the last two years taught us and what can we expect from the next year? The year that everything changed 2020 was a year neither of us was prepared for. Due to the COVID-19 pandemic, the world was closed until mid-March, sporting events were canceled and land casinos closed. The operators were preparing for a difficult time,
Lire la suite

Tremendous scope for India-US cooperation in health technology and pharma, says expert

Image
As the US government stepped up its support to India in its fight against a deadly wave of COVID-19, an Indian public health expert pointed out the enormous scope for collaboration between India and the US on health technology and pharmaceuticals. "Now that we are out of the crisis, health technology and pharmaceuticals are two areas where there is tremendous scope for India-US collaboration," said Indian official Dr. Mrinalini Darswal, who is currently doing a PhD in public health with a focus on COVID-19 at Harvard University, tells. Darswal, a 2002 IAS officer for Odisha cadres, said India had demonstrated its expertise in the health sector, particularly in terms of speed of innovation, manufacturing and cost efficiency. It would be beneficial for the US to leverage India's technical expertise and installed drug manufacturing capabilities to source healthcare equipment, drugs, personal protective equipment and vaccines now at competitive prices, she said. "
Lire la suite

Global Home Sleep Screening Wearable Devices Market Insights Report, Forecast to 2027 – KSU

Image
This latest report on Portable Home Sleep Screening Devices published by Global Market Monitor covers current market dynamics, and offers effective competitive strategies and market guidelines for the majority of practitioners. Get a sample copy of the Wearable Home Sleep Screening Devices Market report at: https://www.globalmarketmonitor.com/request.php?type=1&rid=655284 Main manufacture: To gain an insight into the competitive landscape, the report provides an overview of the major players in the Portable Devices for Home Sleep Screening Market including: ResMed VirtuOx Itamar Medical Royal Philips SleepWorks Cleveland Medical Devices Responsive surface technology Huawei Fitbit This is sleep dreams Garmin Huami ApnoeMed Simmons Bedding Company NovaSom Fossil group Take a look at the comprehensive analysis on different segments: https://www.globalmarketmonitor.com/reports/655284-home-sleep-screening-wearable-devices-market-report.html Home Sleep Screening Wearable
Lire la suite